MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

Other languages Medical Developments International Limited

Equities

MVP

AU000000MVP2

Delayed Australian S.E. Other stock markets 01:16:16 2024-05-07 am EDT			5-day change	1st Jan Change
0.44 ^AUD	-3.30%		-7.37%	-42.11%

Apr. 29	Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
Feb. 29	Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023	23-08-30
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30
Medical Developments International Limited Announces Resignation of David Williams from Board	23-04-17
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US	23-04-11
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%	23-01-17
Medical Developments International Limited Discontinues China Clinical Trials	23-01-17
Medical Developments International Limited Provides Revenue Guidance for the Year 2023	22-09-25
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022	22-09-25
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike	22-08-04
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023	22-08-03
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022	22-05-29
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited	22-05-10
Medical Developments International Limited Announces Board Changes	22-05-04
Australian Shares Post Modest Gains as GDP Rebounds in Q4 2021	22-03-02
Medical Developments Secures US FDA Approval for Phase 3 Pain Medication Trial; Shares Surge 30%	22-03-01
Medical Developments International Limited Announces That US Food and Drug Administration Lifts Clinical Hold on Penthrox	22-03-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Medical Developments International Limited

Equities

MVP

AU000000MVP2

Other languages

Filters